Pancreas transplantation today: quo vadis?

Autor: Abdulrahman O Al-Naseem, Ahmed Attia, Ahmed Reda Gonnah, Abdulaziz O A S Al-Naseem, Harry V M Spiers, Angelika Gruessner, Lalantha Leelarathna, Hood Thabit, Titus Augustine

Publikováno v: Al-Naseem, A O, Attia, A, Gonnah, A R, Al-Naseem, A O A S, Spiers, H V M, Gruessner, A, Leelarathna, L, Thabit, H & Augustine, T 2023, ' Pancreas Transplantation Today: Quo Vadis? ', European Journal of Endocrinology, vol. 188, no. 4, pp. R73-R87 . https://doi.org/10.1093/ejendo/lvad032

Successful pancreas or islet transplantation is currently the only cure for type 1 diabetes mellitus. Since the first pancreas transplant in 1966, there have been various refinements of surgical technique along with improved immunosuppressive regimen

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e01a3f43c00f12bfe2058ffdaad330d
https://doi.org/10.1093/ejendo/lvad032

Real-World Outcomes of Glucose Sensor Use in Type 1 Diabetes—Findings from a Large UK Centre

Autor: Kyuhan Lee, Shakthi Gunasinghe, Alyson Chapman, Lynne A. Findlow, Jody Hyland, Sheetal Ohol, Andrea Urwin, Martin K. Rutter, Jonathan Schofield, Hood Thabit, Lalantha Leelarathna

Publikováno v: Biosensors, Vol 11, Iss 11, p 457 (2021)

Flash glucose monitoring (FGM) and real-time continuous glucose monitoring (RT-CGM) are increasingly used in clinical practice, with improvements in HbA1c and time in range (TIR) reported in clinical studies. We aimed to evaluate the impact of FGM an

Externí odkaz: https://doaj.org/article/2ef86de035a34cff94019bb89f5ec5ae

Review for 'A co‐formulation of pramlintide and insulin A21G (ADO09) improves post‐prandial glucose and short‐term control of mean glucose, time in range, and body weight versus insulin aspart in adults with type 1 diabetes'

Autor: Hood Thabit

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7660f2e3c4cfcccd66f34d2766ad46f2
https://doi.org/10.1111/dom.14972/v2/review1

Safety of User-Initiated Intensification of Insulin Delivery Using Cambridge Hybrid Closed-Loop Algorithm

Autor: Julia Ware, Malgorzata E. Wilinska, Yue Ruan, Janet M. Allen, Charlotte K. Boughton, Sara Hartnell, Lia Bally, Carine de Beaufort, Rachel E. J. Besser, Fiona M. Campbell, Katharine Draxlbauer, Daniela Elleri, Mark L. Evans, Elke Fröhlich-Reiterer, Atrayee Ghatak, Sabine E. Hofer, Thomas M. Kapellen, Lalantha Leelarathna, Julia K. Mader, Womba M. Mubita, Parth Narendran, Tina Poettler, Birgit Rami-Merhar, Martin Tauschmann, Tabitha Randell, Hood Thabit, Ajay Thankamony, Nicola Trevelyan, Roman Hovorka

Publikováno v: Ware, Julia; Wilinska, Malgorzata E; Ruan, Yue; Allen, Janet M; Boughton, Charlotte K; Hartnell, Sara; Bally, Lia; de Beaufort, Carine; Besser, Rachel E J; Campbell, Fiona M; Draxlbauer, Katharine; Elleri, Daniela; Evans, Mark L; Fröhlich-Reiterer, Elke; Ghatak, Atrayee; Hofer, Sabine E; Kapellen, Thomas M; Leelarathna, Lalantha; Mader, Julia K; Mubita, Womba M; ... (2022). Safety of User-Initiated Intensification of Insulin Delivery Using Cambridge Hybrid Closed-Loop Algorithm. (In Press). Journal of diabetes science and technology, p. 19322968221141924. Diabetes Technology Society 10.1177/19322968221141924

Objective: Many hybrid closed-loop (HCL) systems struggle to manage unusually high glucose levels as experienced with intercurrent illness or pre-menstrually. Manual correction boluses may be needed, increasing hypoglycemia risk with overcorrection.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28ed4b5179ed8107a761e3c6f75cd1f2
https://pubmed.ncbi.nlm.nih.gov/36475908

Intermittently Scanned Continuous Glucose Monitoring for Type 1 Diabetes

Autor: Lalantha, Leelarathna, Mark L, Evans, Sankalpa, Neupane, Gerry, Rayman, Sarah, Lumley, Iain, Cranston, Parth, Narendran, Katharine, Barnard-Kelly, Christopher J, Sutton, Rachel A, Elliott, Vicky P, Taxiarchi, Georgios, Gkountouras, Matthew, Burns, Womba, Mubita, Naresh, Kanumilli, Maisie, Camm, Hood, Thabit, Emma G, Wilmot, Ethan, Barnard

In persons with type 1 diabetes and high glycated hemoglobin levels, the benefits of intermittently scanned continuous glucose monitoring with optional alarms for high and low blood glucose levels are uncertain.In a parallel-group, multicenter, rando

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3824fc4c289ce0a2b40ad38e131d1c3